Corona- and related viruses : current concepts in molecular biology and pathogenesis; [proceedings of the Sixth International Symposium on Corona- and Related Viruses, held August 27-September 1, 1994, in Québec City, Québec, Canada] / ed. by Pierre J. Talbot ...
Medienart: |
Buch |
---|
Erscheinungsjahr: |
1995 |
---|---|
Erschienen: |
New York London: Plenum Press ; 1995 |
Reihe: |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Talbot, Pierre [HerausgeberIn] |
---|---|
Congresses: |
International Symposium on Corona- and Related Viruses ; 6 ; Québec ; 1994 International Symposium on Corona and Related Viruses ; 6 ; Québec ; 1994.08.27-09.01 |
ISBN: |
---|
Nlm: |
QW 168.5.C8 |
---|---|
BKL: | |
Themen: |
Coronaviren |
RVK: |
---|
Anmerkungen: |
Includes bibliographical references and index |
---|
Umfang: |
XVII, 615 S. ; Ill., graph. Darst. |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
274718324 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 274718324 | ||
003 | DE-627 | ||
005 | 20230427225521.0 | ||
007 | tu | ||
008 | 960409s1995 xxu||||| 00| ||eng c | ||
010 | |a 95-37889 | ||
016 | 7 | |a b9587866 |2 UK | |
020 | |a 0306451174 |9 0-306-45117-4 | ||
035 | |a (DE-627)274718324 | ||
035 | |a (DE-576)051330539 | ||
035 | |a (DE-599)GBV274718324 | ||
035 | |a (OCoLC)246845078 | ||
035 | |a (OCoLC)832585975 | ||
035 | |a (OCoLC)246845078 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
044 | |c XD-US |c XA-GB | ||
050 | 0 | |a QR399 | |
060 | 0 | |a QW 168.5.C8 | |
082 | 0 | |a 616.0194 | |
082 | 0 | |a 616/.0194 | |
084 | |a XD 7955 |2 rvk |0 (DE-625)rvk/152605:13134 | ||
084 | |a XD 7950 |2 rvk |0 (DE-625)rvk/152605:13129 | ||
084 | |a 42.32 |2 bkl | ||
084 | |a 44.75 |2 bkl | ||
245 | 1 | 0 | |a Corona- and related viruses |b current concepts in molecular biology and pathogenesis; [proceedings of the Sixth International Symposium on Corona- and Related Viruses, held August 27-September 1, 1994, in Québec City, Québec, Canada] |c ed. by Pierre J. Talbot ... |
264 | 1 | |a New York |a London |b Plenum Press |c 1995 | |
300 | |a XVII, 615 S. |b Ill., graph. Darst. | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
490 | 1 | |a Advances in experimental medicine and biology |v 380 | |
500 | |a Includes bibliographical references and index | ||
583 | 1 | |a Archivierung prüfen |c 20200919 |f DE-640 |z 1 |2 pdager | |
650 | 0 | |a Coronavirus infections |x Congresses | |
650 | 0 | |a Coronaviruses |x Congresses | |
650 | 0 | |a Coronavirus infections |x Congresses | |
650 | 0 | |a Coronaviruses |x Congresses | |
650 | 2 | |a Coronaviridae |x congresses | |
655 | 7 | |a Konferenzschrift |y 1994 |z Québec |0 (DE-588)1071861417 |0 (DE-627)826484824 |0 (DE-576)433375485 |2 gnd-content | |
655 | 7 | |a Konferenzschrift |0 (DE-588)1071861417 |0 (DE-627)826484824 |0 (DE-576)433375485 |2 gnd-content | |
689 | 0 | 0 | |D s |0 (DE-588)4276392-7 |0 (DE-627)104430672 |0 (DE-576)210718978 |a Coronaviren |2 gnd |
689 | 0 | |5 (DE-627) | |
689 | 1 | 0 | |D s |0 (DE-588)4276392-7 |0 (DE-627)104430672 |0 (DE-576)210718978 |a Coronaviren |2 gnd |
689 | 1 | 1 | |D s |0 (DE-588)4026879-2 |0 (DE-627)104288914 |0 (DE-576)208968350 |a Infektionskrankheit |2 gnd |
689 | 1 | |5 (DE-627) | |
689 | 2 | 0 | |D s |0 (DE-588)4188401-2 |0 (DE-627)105264830 |0 (DE-576)210052554 |a Virusinfektion |2 gnd |
689 | 2 | |5 (DE-627) | |
700 | 1 | |a Talbot, Pierre |e hrsg |0 (DE-588)1158293496 |0 (DE-627)1021972231 |0 (DE-576)503770620 |4 edt | |
700 | 1 | |a Levy, Gary A. |4 oth | |
711 | 2 | |a International Symposium on Corona- and Related Viruses |n 6 |d 1994 |c Québec |0 (DE-588)1301933-8 |0 (DE-627)192110519 |0 (DE-576)195660285 |4 oth | |
711 | 2 | 9 | |a International Symposium on Corona and Related Viruses |n 6 |c Québec |d 1994.08.27-09.01 |
830 | 0 | |a Advances in experimental medicine and biology |v 380 |9 380 |w (DE-627)129970778 |w (DE-576)015534642 |w (DE-600)410187-X |x 0065-2598 |7 ns | |
889 | |w (DE-627)187805946 | ||
912 | |a GBV_ILN_11 | ||
912 | |a ISIL_DE-1a | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_22 | ||
912 | |a ISIL_DE-18 | ||
912 | |a GBV_ILN_22_i06404 | ||
912 | |a GBV_ILN_24 | ||
912 | |a ISIL_DE-8 | ||
912 | |a GBV_ILN_40 | ||
912 | |a ISIL_DE-7 | ||
912 | |a GBV_ILN_55 | ||
912 | |a ISIL_DE-Goe116 | ||
912 | |a GBV_ILN_74 | ||
912 | |a ISIL_DE-354 | ||
912 | |a GBV_ILN_252 | ||
912 | |a GBV_ILN_252_i100 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a ISIL_DE-15 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a ISIL_DE-289 | ||
935 | |i mdedup | ||
935 | |i Blocktest | ||
936 | r | v | |a XD 7955 |b Kongress, Tagungsbericht, Fortbildungslehrgang, Symposium |k Medizin |k Medizinische Mikrobiologie |k Spezielle medizinische Mikrobiologie |k Virologie |k Taxonomische Einteilung (nach chemischen Eigenschaften) |k RNA-Viren |k Einzelsträngige RNA: Picornaviren, Togaviren, Bunyaviren, Paramyxoviren, Rhabdoviren, Arenaviren Coronaviren |k Kongress, Tagungsbericht, Fortbildungslehrgang, Symposium |0 (DE-627)1272432777 |0 (DE-625)rvk/152605:13134 |0 (DE-576)202432777 |
936 | r | v | |a XD 7950 |b Allgemeines |k Medizin |k Medizinische Mikrobiologie |k Spezielle medizinische Mikrobiologie |k Virologie |k Taxonomische Einteilung (nach chemischen Eigenschaften) |k RNA-Viren |k Einzelsträngige RNA: Picornaviren, Togaviren, Bunyaviren, Paramyxoviren, Rhabdoviren, Arenaviren Coronaviren |k Allgemeines |0 (DE-627)1271521679 |0 (DE-625)rvk/152605:13129 |0 (DE-576)201521679 |
936 | b | k | |a 42.32 |j Virologie |x Biologie |0 (DE-627)106404733 |
936 | b | k | |a 44.75 |j Infektionskrankheiten |j parasitäre Krankheiten |x Medizin |0 (DE-627)106415948 |
951 | |a BO | ||
953 | |2 045F |a 616.0194 | ||
953 | |2 045F |a 616/.0194 | ||
980 | |2 11 |1 01 |x 0001 |b 027358208 |c 00 |f 2 |d 1 B 44915 |e u |j --%%-- |y r |z 20-05-96 | ||
980 | |2 22 |1 01 |x 0018 |b 215387597 |c 00 |f 18/64 |d Med Y/496: 380 |e b |j --%%-- |y zi06404 |z 30-09-96 | ||
980 | |2 24 |1 01 |x 8/202 |b 16827289X |c 00 |f 29 |d MU 1020-380 |e u |j --%%-- |h ma |y zz1 |z 05-12-95 | ||
980 | |2 40 |1 01 |x 7/11 |b 177794771 |c 00 |f BBM |d XS 283 049 = ZB 28557:380 |e u |j --%%-- |c 09 |f --%%-- |d ZB 28557:380 |e --%%-- |j --%%-- |y xsn |z 14-03-96 | ||
980 | |2 55 |1 01 |x 3055 |b 168007649 |c 00 |f --%%-- |d G 1/01 |e --%%-- |j --%%-- |y z |z 30-11-95 | ||
980 | |2 74 |1 01 |x 0354 |b 169305740 |c 00 |f Magazin |d Z 1334-380 |e u |j --%%-- |y r |z 13-01-10 | ||
980 | |2 252 |1 01 |x 4252/100 |b 64032603X |c 00 |f Gr61 |d 21/155[380] |e i |j --%%-- |y zi100 |z 23-03-04 | ||
980 | |2 2010 |1 01 |x DE-15 |b 3113291453 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 23-04-96 | ||
980 | |2 2021 |1 01 |x DE-289 |b 3113291518 |c 00 |f J |d QW 168.5.C8/1994 T |e --%%-- |j --%%-- |y l01 |z 09-04-96 | ||
982 | |2 24 |1 01 |x 8/202 |8 00 |a Coronavirus | ||
982 | |2 24 |1 01 |x 8/202 |8 00 |a Molekularbiologie | ||
982 | |2 24 |1 01 |x 8/202 |8 00 |a Infektionskrankheit | ||
982 | |2 24 |1 01 |x 8/202 |8 00 |a Kongress | ||
982 | |2 74 |1 00 |x DE-354 |8 00 |a Coronavirus | ||
982 | |2 74 |1 00 |x DE-354 |8 01 |a Coronavirus Infections | ||
982 | |2 74 |1 00 |x DE-354 |8 50 |a Congresses | ||
982 | |2 2021 |1 01 |x DE-289 |8 00 |s s |0 (DE-627)130618956X |a Coronavirus infections. Congresses | ||
983 | |2 11 |1 00 |x DE-1a |8 00 |0 (DE-627)287595676 |a Med G 491; Coronaviren | ||
983 | |2 11 |1 00 |x DE-1a |8 01 |0 (DE-627)290973325 |a Bio B 2491; Coronaviren | ||
983 | |2 24 |1 01 |x 8/202 |8 50 |0 (DE-627)058016724 |a mdk 679 |b Coronavireninfektionen. Coxsackievireninfektionen. Enterovireninfektionen. Reovireninfektionen. Retrovireninfektionen | ||
983 | |2 40 |1 00 |x DE-7 |8 00 |0 (DE-627)619875186 |a MED 283 |b Molekularbiologie {Medizin} | ||
983 | |2 40 |1 00 |x DE-7 |8 01 |0 (DE-627)619875372 |a MED 332 |b Medizinische Virologie | ||
984 | |2 11 |1 01 |x 0001 |a 118543310010 | ||
984 | |2 22 |1 01 |x 0018 |a 056013564 | ||
984 | |2 40 |1 01 |x 7/11 |a 7$203988140 | ||
984 | |2 74 |1 01 |x 0354 |a 354$10740945 | ||
984 | |2 252 |1 01 |x 4252/100 |a GR61$0014311 | ||
985 | |2 74 |1 01 |x 0354 |a Z 1334-380 | ||
985 | |2 252 |1 01 |x 4252/100 |a 2000.304/Nachlaß/Wege | ||
995 | |2 24 |1 01 |x 8/202 |a ma |